Monitoring nebuliser usage & lung function in clinical trials.
Monitoring nebuliser usage & lung function in clinical trials.
Explore the latest news and publications, innovation milestones, and drug-device insights from PARI and our pharmaceutical partners leveraging eFlow® Technology.
Scientific publications authored or co-authored by PARI experts, highlighting advancements and key findings in aerosol science and inhaled drug delivery.
Monitoring nebuliser usage & lung function in clinical trials.
Monitoring adherence to treatment regimen of inhaled medication use in a clinical trial with an investigational eFlow nebulizer (eTrack).
In-vitro Study of Aerosolised Colistin Delivered to the Nasal Tract via a Pulsating Aerosol Delivery Device (Vibrent®).
The eFlow ‘‘closed system’’(CS) - a novel device platform for liquid aerosol drug-device combinations.
Pulsating Aerosols - New Therapy Options for Upper Airway Diseases.